Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning
Creators
- 1. EORTC Headquarters, Brussels (Belgium)
- 2. Radiation-Oncology Department, Institute Curie - Rene Huguenin Hospital, Saint-Cloud (France)
- 3. Radiation-Oncology Department, Maastricht University Medical Centre (MUMC) (Netherlands)
- 4. Oncology Department, Rambam Medical Center, Haifa (Israel)
- 5. Centre Hospitalier Universitaire Vaudois, University of Lausanne (Switzerland)
- 6. Radiation Oncology Department, Geneva University Hospital (Switzerland)
- 7. Radiation Oncology Clinic and Policlinic, University Hospital, Zurich (Switzerland)
- 8. Medical Physics Department, Mount Vernon Hospital, Northwood, Middlesex (United Kingdom)
Description
Purpose: Early assessment of radiotherapy (RT) quality in the ongoing EORTC trial comparing primary temozolomide versus RT in low-grade gliomas. Materials and methods: RT plans provided for dummy cases were evaluated and compared against expert plans. We analysed: (1) tumour and organs-at-risk delineation, (2) geometric and dosimetric characteristics, (3) planning parameters, compliance with dose prescription and Dmax for OAR (4) indices: RTOG conformity index (CI), coverage factor (CF), tissue protection factor (PF); conformity number (CN = PF x CF); dose homogeneity in PTV (U). Results: Forty-one RT plans were evaluated. Only two (5%) centres were requested to repeat CTV-PTV delineations. Three (7%) plans had a significant under-dosage and dose homogeneity in one deviated >10%. Dose distribution was good with mean values of 1.5, 1, 0.68, and 0.68 (ideal values = 1) for CI, CF, PF, and CN, respectively. CI and CN strongly correlated with PF and they correlated with PTV. Planning with more beams seems to increase PTVDmin, improving CF. U correlated with PTVDmax. Conclusion: Preliminary results of the dummy run procedure indicate that most centres conformed to protocol requirements. To quantify plan quality we recommend systematic calculation of U and either CI or CN, both of which measure the amount of irradiated normal brain tissue.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.radonc.2010.03.005Additional details
Identifiers
- DOI
- 10.1016/j.radonc.2010.03.005;
- PII
- S0167-8140(10)00156-8;
Publishing Information
- Journal Title
- Radiotherapy and Oncology
- Journal Volume
- 95
- Journal Issue
- 2
- Journal Page Range
- p. 218-224
- ISSN
- 0167-8140
- CODEN
- RAONDT
INIS
- Country of Publication
- Ireland
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 41074449
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BRAIN; EVALUATION; GLIOMAS; HAZARDS; PLANNING; QUALITY ASSURANCE; RADIATION DOSE DISTRIBUTIONS; RADIATION DOSES; RADIOTHERAPY
- Descriptors DEC
- BODY; CENTRAL NERVOUS SYSTEM; DISEASES; DOSES; MEDICINE; NEOPLASMS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY
Optional Information
- Copyright
- Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.